You conduct a clinical trial to test whether a new drug relieves the symptoms of arthritis better than

a placebo. You have four groups of participants, all of whom have moderately painful arthritis (rated 7 on

a scale of 1 to 10). Each group receives a daily pill as follows: group 1—placebo; group 2—15 mg; group

3—25 mg; group 4—50 mg. At the end of 2 weeks, participants in each group are asked to rate their pain

on a scale of 1 to 10.

Based on the process of science, what should your next step be?

A). invest in the drug company

B). conclude that the drug relieves arthritis pain

C). run a statistical analysis on the data collected

D). develop a new hypothesis based on the unanalyzed data